Nasta SD, Hoff PM, George CS, Neubauer M, Cohen SC, Abbruzzese J, Winn R, Pazdur RM. Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 2003 Apr;26(2):132–4. doi: 10.1097/01.coc.0000017092.65803.76.